- All
- 2026-06-11 [Thursday]
- 2026-06-12 [Friday]
- 2026-06-13 [Saturday]
- 2026-06-14 [Sunday]
- All
- A1-A (102-107)
- A1-A101
- A1-A102
- A1-A103
- A1-A104
- A1-A (105-107)
- A1-A108
- A1-A109
- A1-A110
- A2-A206
- A2-A207
- A2-A208
- A2-A213
- A2-A214
- A2-A215
- B1 Hall (Poster Area)
- B1 Hall (Exhibition Area)
2026-06-13 (Saturday)
A2-A207
| NO. | Time | Presentation Topic | Speaker | Affiliation / Organization |
|---|---|---|---|---|
| 1 | 08:00-08:06 |
Application and Mechanistic Investigation of Idarubicin-Loaded EqualSphere Drug-Eluting Microspheres in a VX2 Rabbit Liver Tumor Model |
Zhe-Yu Jiang | Affiliated Hospital of Guizhou Medical University, China |
| 2 | 08:08-08:14 |
Medical and social aspects of primary liver cancer in Kazakhstan. |
Niyaz Malayev | National Scientific Medical Center, Kazakhstan |
| 3 | 08:16-08:22 |
Globe-Salvage Outcomes of Intra-Arterial Chemotherapy for Retinoblastoma through Main and Alternative Routes: A Single-Centre Experience in Indonesia |
Gideon Hot Partogi Sinaga | Faculty of Medicine, Universitas Indonesia |
| 4 | 08:24-08:30 |
Ruptured Liver Tumors: Why Not Emergency TACE? Experience from Cho Ray Hospital, a High-Volume Hepatobiliary Intervention Center in Vietnam |
Long Hoang Than Ton | The VietNamese Society of Radiology and Nuclear Medicine (VSRNM), Vietnam |
| 5 | 08:32-08:38 |
Microwave Ablation Combined with TACE and Targeted Immunotherapy for Large Hepatocellular Carcinoma: Subgroup Efficacy Analysis Based on Lesion Characteristics, Liver Function, and Staging |
Jian Li | Qingdao university, China |
| 6 | 08:40-08:46 |
Outcomes of Transarterial Embolization for Large Symptomatic Focal Nodular Hyperplasia in 17 Pediatric Patients |
Jie-Yu Yan | The First Medical Center of PLA General Hospital, China |
| 7 | 08:48-08:54 |
Adjuvant Hyperbaric Oxygen Therapy with Drug-Eluting Bead Transarterial Chemoembolization for Hepatocellular Carcinoma: A Pilot Study on Efficacy and Safety |
Rui An | Xijing Hospital, The Fourth Military Medical University, China |
| 8 | 08:56-09:02 |
Tumor Protrusion Assessment and Clinical Integration for Enhanced Mortality Risk Prediction in Spontaneously Ruptured Hepatocellular Carcinoma |
Wasittee Ajanakitti | PSU Minimally Invasive Surgical-Interventional Radiology Center, Faculty of Medicine, Prince of Songkla University, Songkhla, Thailand |
| 9 | 09:04-09:10 |
Transarterial Chemoembolization of Giant Liver Hemangiomas with Lipiodol–Bleomycin Emulsion: What We Know and What We Do Not Know |
Shahram Akhlaghpour | Pardis Noor Medical Imaging and Cancer Center, Iran |
| 10 | 09:12-09:18 |
Non-invasive Assessment of Portal Hypertension Predicts Poor Prognosis in HCC Patients Receiving TACE plus Immunotherapy and Targeted Therapy: A Multicenter Cohort Study |
Yu-Qing Wang | Zhongda Hospital, Southeast University, China |
